Barriers to Human Papillomavirus Vaccine Acceptability in Israel

Fisher, William A.; Laniado, Hila; Shoval, Hila; Hakim, Marwan; Bornstein, Jacob

doi:10.1016/j.vaccine.2013.06.107

Cited by 21 publications

(19 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This probably explains the very low percentage of HPV immunized girls in this study. [21]. The role of governmental policy in the implementation of the vaccine is relevant as some women even reported it wrongly as being part of the current national immunization programme in Nigeria.…”

Section: Knowledge Of Hpv Infection and Vaccinementioning

confidence: 99%

“…The willingness to accept HPV vaccine was low and there was a significant statistical difference between acceptability and knowledge of HPV infection and vaccination, and cervical cancer. Where others reported high acceptability [18][19][20][21][22][23][24] This strategy would eliminate cost as a factor that may limit the acceptability and willingness of parents to vaccinate their wards and children.…”

Section: Knowledge Of Hpv Infection and Vaccinementioning

confidence: 99%

See 1 more Smart Citation

Knowledge, practice and acceptability of HPV vaccine by mothers of adolescent girls in Ilorin, Nigeria

Adesina¹,

Saka²,

Isiaka-Lawal³

et al. 2018

SJMS

View full text Add to dashboard Cite

show abstract

Section: Knowledge Of Hpv Infection and Vaccinementioning

confidence: 99%

Section: Knowledge Of Hpv Infection and Vaccinementioning

confidence: 99%

Knowledge, practice and acceptability of HPV vaccine by mothers of adolescent girls in Ilorin, Nigeria

Adesina¹,

Saka²,

Isiaka-Lawal³

et al. 2018

SJMS

View full text Add to dashboard Cite

show abstract

“…Several factors have influenced the slow introduction of the anti-HPV vaccination in the region: financial constraints, poor infrastructure for adolescent vaccine delivery, competition with high-priority vaccines and the lack of reliable data on the burden of HPV diseases (8)(9)(10). However, the main obstacle to an effective introduction of the anti-HPV vaccine is still the low political will that is often justified by cultural and religious sensitivities, which could limit the success of such vaccination programmes (11).…”

Section: Introductionmentioning

confidence: 99%

Knowledge, awareness and acceptability of anti-HPV vaccine in the Arab states of the Middle East and North Africa Region: a systematic review

Gamaoun¹

2018

East Mediterr Health J

View full text Add to dashboard Cite

show abstract

“…Uptake in Israel has differed across the country, with similar barriers reported elsewhere, e.g. religious beliefs, vaccine cost, and awareness [47,48]. By October 2014, in Africa and Asia, only 1-2% of females aged 10-20 years received one dose of the HPV vaccine, compared to 53.4% in Northern America, 36.4% in Europe, 41.1% in Oceania, and 22.1% in Latin America and the Caribbean [6].…”

Section: Figmentioning

confidence: 65%

Human Papillomavirus Vaccines: Successes and Future Challenges

Perez

Zimet

Tatar

et al. 2018

Drugs

Self Cite

View full text Add to dashboard Cite

Over a decade has passed since the first human papillomavirus (HPV) vaccine was introduced. These vaccines have received unequivocal backing from the scientific and medical communities, yet continue to be debated in the media and within the public. The current review is an updated examination that the authors made 5 years ago on some of the key sociocultural and behavioral issues associated with HPV vaccine uptake and acceptability, given the changing vaccine policies and beliefs worldwide. We explore current worldwide HPV vaccination rates, outline HPV vaccine policies, and revisit critical issues associated with HPV vaccine uptake including: risk compensation, perceptions of vaccine safety and efficacy, age of vaccination, and healthcare provider (HCP) recommendation and communication. While public scrutiny of the vaccine has not subsided, empirical evidence supporting its safety and efficacy beyond preventing cervical cancer has amassed. There are conclusive findings showing no link that vaccinated individuals engage in riskier sexual behaviors as a result of being immunized (risk compensation) both at the individual and at the policy level. Finally, HCP recommendation continues to be a central factor in vaccine uptake. Studies have illuminated how HCP practices and communication enhance uptake and alleviate misperceptions about vaccination. Strategies such as bundling vaccinations, allowing nurses to vaccinate via "standing orders," and diversifying vaccination settings (e.g., pharmacies) may be effective steps to increase rates. The successes of vaccination outweigh the controversy, but as the incidence of HPV-related cancers rises, it is imperative that future research on HPV vaccine acceptability continues to identify effective and targeted strategies to inform HPV vaccination programs and improve HPV coverage rates worldwide.

show abstract

Barriers to Human Papillomavirus Vaccine Acceptability in Israel

Cited by 21 publications

References 19 publications

Knowledge, practice and acceptability of HPV vaccine by mothers of adolescent girls in Ilorin, Nigeria

Knowledge, practice and acceptability of HPV vaccine by mothers of adolescent girls in Ilorin, Nigeria

Knowledge, awareness and acceptability of anti-HPV vaccine in the Arab states of the Middle East and North Africa Region: a systematic review

Human Papillomavirus Vaccines: Successes and Future Challenges

Contact Info

Product

Resources

About